Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Reid

Showing results (71-80 of 589) with videos related to

Pageof 59
Sort By:
Cardiovascular Therapeutics|September 3, 2011
Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian CohortZanfina Ademi, Danny Liew, Bruce Hollingsworth, et al.
Heart & Lung : the Journal of Critical Care|November 3, 2021
Antihypertensive drug class in combination with lipid lowering treatment for primary prevention of cardiovascular disease in the elderlyZhen Zhou, Enayet K Chowdhury, Monique Breslin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2010
Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registryZanfina Ademi, Danny Liew, Bruce Hollingsworth, et al.
Cardiology Journal|June 27, 2013
Training surgeon status is not associated with an increased risk of early or late mortality after isolated aortic valve replacement surgeryAkshat Saxena, Diem Dinh, Julian A Smith, et al.
Journal of Hypertension|September 4, 2015
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure studyMark R Nelson, Enayet K Chowdhury, Jenny Doust, et al.
Journal of Hypertension|March 23, 2002
'Reverse white-coat hypertension' in older hypertensivesLindon M H Wing, Mark A Brown, Lawrence J Beilin, et al.
Annals of Plastic Surgery|March 16, 2017
Analysis of a Resident Aesthetic Clinic: Process for Rhinoplasty, Resident Experience, and Patient SatisfactionMichael G Brandel, Gehaan F DʼSouza, Christopher M Reid, et al.
Medicine|March 5, 2015
Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidityEnayet K Chowdhury, Zanfina Ademi, John R Moss, et al.
Clinical and Experimental Pharmacology & Physiology|April 10, 2015
Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modellingThilanga Ruwanpathirana, Alice Owen, Andre M N Renzaho, et al.
The Journal of Surgical Research|May 28, 2016
Are self-identified "disadvantaged" students less likely to enter surgical residencies? A single-institution studyJonathan T Unkart, Christopher M Reid, Joel M Baumgartner, et al.
Pageof 59

Showing results (71-80 of 589) with videos related to

Sort By:
Pageof 59
Cardiovascular Therapeutics|September 3, 2011
Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian CohortZanfina Ademi, Danny Liew, Bruce Hollingsworth, et al.
Heart & Lung : the Journal of Critical Care|November 3, 2021
Antihypertensive drug class in combination with lipid lowering treatment for primary prevention of cardiovascular disease in the elderlyZhen Zhou, Enayet K Chowdhury, Monique Breslin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2010
Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registryZanfina Ademi, Danny Liew, Bruce Hollingsworth, et al.
Cardiology Journal|June 27, 2013
Training surgeon status is not associated with an increased risk of early or late mortality after isolated aortic valve replacement surgeryAkshat Saxena, Diem Dinh, Julian A Smith, et al.
Journal of Hypertension|September 4, 2015
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure studyMark R Nelson, Enayet K Chowdhury, Jenny Doust, et al.
Journal of Hypertension|March 23, 2002
'Reverse white-coat hypertension' in older hypertensivesLindon M H Wing, Mark A Brown, Lawrence J Beilin, et al.
Annals of Plastic Surgery|March 16, 2017
Analysis of a Resident Aesthetic Clinic: Process for Rhinoplasty, Resident Experience, and Patient SatisfactionMichael G Brandel, Gehaan F DʼSouza, Christopher M Reid, et al.
Medicine|March 5, 2015
Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidityEnayet K Chowdhury, Zanfina Ademi, John R Moss, et al.
Clinical and Experimental Pharmacology & Physiology|April 10, 2015
Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modellingThilanga Ruwanpathirana, Alice Owen, Andre M N Renzaho, et al.
The Journal of Surgical Research|May 28, 2016
Are self-identified "disadvantaged" students less likely to enter surgical residencies? A single-institution studyJonathan T Unkart, Christopher M Reid, Joel M Baumgartner, et al.
Pageof 59